Literature DB >> 11745188

Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1992-1997.

X Cheng1, V W Chen, B Steele, B Ruiz, J Fulton, L Liu, S E Carozza, R Greenlee.   

Abstract

BACKGROUND: Subsite specific incidence rates of colorectal cancer vary considerably by age, gender, and race. This variation may be related not only to distinctions in exposure to genetic and environment factors but also to current strategies of early detection screening. Patterns of stage of disease in anatomic subsite may reflect the effect of screening. This study used the largest aggregation of cancer incidence data in the U.S. to examine subsite specific incidence rates of colorectal cancer and the relation of stage of disease to anatomic subsites by race, gender, and age group.
METHODS: Data on the incidence of invasive colorectal cancer were obtained from 28 population-based central cancer registries. Age-specific and age-adjusted rates and stage distributions were analyzed by subsite, race, and gender.
RESULTS: The impact of screening can be observed in the percentage of localized disease, which increased from 31.9% among cancers in the proximal colon to 37.0% in the descending colon to 41.5% in the distal colorectum. Within the same subsite, blacks were less likely than whites to receive a diagnosis of localized disease and more likely to receive a diagnosis of distant disease whereas stage distributions were approximately the same for males and females. Blacks were more likely than whites to receive a diagnosis of proximal colon cancer than distal colorectal cancer. The male-to-female rate ratios progressively increased from the proximal colon to the distal colorectum. The ratios of proximal-to-distal colorectal cancer gradually increased with advancing age.
CONCLUSIONS: Differentials in stage of disease by subsites indicate a need for a targeted effort at early detection of cancer in the proximal colon. Risk factors and higher risk populations for colorectal cancers in each subsite need to be studied further to guide actions for improving the efficacy of screening. Copyright 2001 American Cancer Society.

Entities:  

Mesh:

Year:  2001        PMID: 11745188     DOI: 10.1002/1097-0142(20011115)92:10<2547::aid-cncr1606>3.0.co;2-k

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  58 in total

1.  Gender differences in colorectal cancer incidence in the United States, 1975-2006.

Authors:  Peter N Abotchie; Sally W Vernon; Xianglin L Du
Journal:  J Womens Health (Larchmt)       Date:  2011-12-13       Impact factor: 2.681

2.  Stage I colorectal carcinoma: VEGF immunohistochemical expression, microvessel density, and their correlation with clinical outcome.

Authors:  Valeria Barresi; Carmela Di Gregorio; Luca Regiani-Bonetti; Maurizio Ponz-De Leon; Gaetano Barresi; Enrica Vitarelli
Journal:  Virchows Arch       Date:  2010-06-08       Impact factor: 4.064

Review 3.  Diabetes mellitus is an independent risk factor for colorectal cancer.

Authors:  Lei Sun; Shiying Yu
Journal:  Dig Dis Sci       Date:  2012-06       Impact factor: 3.199

4.  Sex disparities in colorectal cancer incidence by anatomic subsite, race and age.

Authors:  Gwen Murphy; Susan S Devesa; Amanda J Cross; Peter D Inskip; Katherine A McGlynn; Michael B Cook
Journal:  Int J Cancer       Date:  2010-05-25       Impact factor: 7.396

5.  Racial disparities in stage-specific colorectal cancer mortality: 1960-2005.

Authors:  Samir Soneji; Shally Shalini Iyer; Katrina Armstrong; David A Asch
Journal:  Am J Public Health       Date:  2010-08-19       Impact factor: 9.308

6.  Local recurrence after rectal cancer treatment in Manitoba.

Authors:  Steven Latosinsky; Donna Turner
Journal:  Can J Surg       Date:  2009-02       Impact factor: 2.089

7.  Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading.

Authors:  Valeria Barresi; Luca Reggiani Bonetti; Giovanni Branca; Carmela Di Gregorio; Maurizio Ponz de Leon; Giovanni Tuccari
Journal:  Virchows Arch       Date:  2012-10-24       Impact factor: 4.064

8.  Adjuvant therapy of colon cancer: current status and future developments.

Authors:  Michael A Morse
Journal:  Clin Colon Rectal Surg       Date:  2005-08

9.  A black-white comparison of the quality of stage-specific colon cancer treatment.

Authors:  Jamillah Berry; Lee Caplan; Sharon Davis; Patrick Minor; Margaret Counts-Spriggs; Roni Glover; Vickie Ogunlade; Kevin Bumpers; John Kauh; Otis W Brawley; Christopher Flowers
Journal:  Cancer       Date:  2010-02-01       Impact factor: 6.860

10.  The contribution of cancer incidence, stage at diagnosis and survival to racial differences in years of life expectancy.

Authors:  Mitchell D Wong; Susan L Ettner; W John Boscardin; Martin F Shapiro
Journal:  J Gen Intern Med       Date:  2009-02-03       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.